Inhalation Anesthesia Market share to grow at 3.5% CAGR from 2017 to 2024: Global Market Insights Inc. In what may be construed as a breakthrough in inhalation anesthesia market, Baxter International Incorporation, a medical products manufacturer, has collaborated with Dorizoe Lifesciences Limited, a CRO firm, to develop over twenty generic injectable high-quality products comprising oncolytics, cardiovascular medicines, and antiinfectives. Baxter had already made it to the headlines earlier this year for its acquisition of Claris injectables limited, a key player across inhalation anesthesia industry, in a bid to expand its geographical presence. Apparently, Claris’ inclusion in its acquisition fold would help the firm consolidate their portfolio of anesthesia and analgesics drug products. Baxter’s unpretentious but powerful penetration in inhalation anesthesia industry underlines its commitment toward the medical and pharma verticals. Driven by the commendable efforts of medical companies and the robust prevalence of chronic ailments leading to the subsequent demand for anesthetics, inhalation anesthesia market size was pegged at USD 1,285.8 million in 2016.
The product landscape of inhalation anesthesia market comprises isoflurane, sevoflurane, and desflurane – essential anesthetics used during crucial surgeries. Sevoflurane among these, is renown to have contributed significantly towards inhalation anesthesia industry revenue in 2016. Subject to favorable product features such as low flammability and intrinsic stability, sevoflurane inhalation anesthesia market share is set to witness a commendable expansion over the next few years. Its counterpart – isoflurane is mostly preferred in neurosurgeries due to its ability to potentiate muscle relaxant activity and assist the expansion of systemic vessels. Considering the rising prevalence of chronic diseases such as cancer across the U.S., in tandem with the high-grade healthcare infrastructure and medical care expenditure of the country, it comes as no surprise that the United States is one of most remunerative avenues for inhalation anesthesia market. Estimates claim that the U.S. dominated the regional market share in 2016, driven by the surging product deployment in plastic surgeries and the growing prevalence of chronic lower respiratory ailments.
1|Page
U.S. Inhalation Anesthesia Market, By Product, 2013 - 2024 (USD Million)
Browse key industry insights spread across 130 pages with 168 market data tables & 9 figures & charts from the report Inhalation Anesthesia Market in detail along with the table of contents: https://www.gminsights.com/industry-analysis/inhalation-anesthesia-market Pertaining to the widespread applications of the product, inhalation anesthesia market has successfully established its presence across many other geographies across the globe, apart from the U.S. Europe inhalation anesthesia industry size for instance, impelled by the thriving economies of UK and Germany, is likely to chart out a profitable growth path in the years ahead. UK, in particular, will register a substantial growth rate over 2017-2024, given the rising prevalence of cancer and the rapidly increasing rate of surgical procedures. Germany apparently, accounted for the highest share in the Europe market, driven by the growing geriatric population suffering from chronic ailments. In fact, as per estimates, cancer and cardiovascular disorders account for more than 66% of deaths in the country – a factor which is slated to upsurge the demand for anesthesia in surgeries, inherently propelling Germany inhalation anesthesia industry size. Inhalation anesthesia market, touted to be one of most profitable business spheres of recent times, has its share of restraints, one of principal ones being, the ill-effects of anesthetic products. Pertaining to the same, companies have been brainstorming ways to innovate contemporary products as per the illness and the level of its seriousness in question.
2|Page
In essence, the undertaking of strategic initiatives and the growing R&D funding are expected to successfully complement inhalation anesthesia market outlook in the forthcoming years. If estimates are to be believed, this business vertical is anticipated to generate a target valuation exceeding USD 1.6 billion by 2024.
Table of Content of Inhalation Anesthesia Market: Chapter 1.
Methodology
1.1. Methodology 1.1.1. Initial data exploration 1.1.2. Statistical modeling and forecast 1.1.3. Industry insights and validation 1.1.4. Market definition 1.1.5. Market definition and forecast assumptions 1.2. Data Sources 1.2.1. Primary 1.2.2. Secondary Chapter 2.
Executive Summary
2.1. Inhalation anesthesia industry 3600 synopsis, 2013 - 2024 2.1.1. Business trends 2.1.2. Product trends 2.1.3. Application trends 2.1.4. Regional trends Chapter 3.
Inhalation Anesthesia Industry Insights
3.1. Industry segmentation 3.2. Industry landscape, 2013 – 2024
3|Page
3.3. Industry impact forces 3.3.1. Growth drivers 3.3.1.1. Increasing incidence of chronic diseases CVS, respiratory, cancer 3.3.1.2. Growing geriatric population 3.3.1.3. Increased number of surgeries performed in ambulatory surgical centers 3.3.2. Industry pitfalls & challenges 3.3.2.1. Adverse effects of anesthesia 3.4. Growth potential analysis 3.4.1. By Product 3.4.2. By Application 3.5. Regulatory landscape 3.5.1. U.S 3.5.2. Europe 3.6. Reimbursement scenario 3.6.1. U.S 3.6.2. Europe 3.7. Porter’s analysis 3.8. Company market share analysis, 2016 3.8.1. Strategy dashboard 3.9. PESTEL analysis
4|Page
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us: Arun Hegde Corporate Sales, USA Global Market Insights, Inc. Phone: 1-302-846-7766 Toll Free: 1-888-689-0688 Email: sales@gminsights.com Website: https://www.gminsights.com/
5|Page